Stabilized formulations containing Anti-bcma x Anti- cd3 bispecific antibodies
PH12026550005A1Pending Publication Date: 2026-09-07REGENERON PHARMACEUTICALS INC
0 Cites 0 Cited by
Patent Information
- Application Number
- PH12026550005
- Authority / Receiving Office
- PH · PH
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2026-01-05
- Publication Date
- 2026-09-07
Need to check novelty before this filing date? Find Prior Art
No text content released.